The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults.
Zhi-Feng ShiKay Ka-Wai LiAnthony Pak-Yin LiuNellie Yuk-Fei ChungSze-Ching WongHong ChenPeter Yat-Ming WooDanny Tat-Ming ChanYing MaoHo Keung NgPublished in: Cancers (2024)
Pediatric brain tumors are often noted to be different from their adult counterparts in terms of molecular features. Primary CNS lymphomas (PCNSLs) are mostly found in elderly adults and are uncommon in children and teenagers. There has only been scanty information about the molecular features of PCNSLs at a young age. We examined PCNSLs in 34 young patients aged between 7 and 39 years for gene rearrangements of BCl2, BCL6, CCND1, IRF4, IGH, IGL, IGK, and MYC, homozygous deletions (HD) of CDKN2A, and HLA by FISH. Sequencing was performed using WES, panel target sequencing, or Sanger sequencing due to the small amount of available tissues. The median OS was 97.5 months and longer than that for older patients with PCNSLs. Overall, only 14 instances of gene rearrangement were found (5%), and patients with any gene rearrangement were significantly older ( p = 0.029). CDKN2A HD was associated with a shorter OS ( p < 0.001). Only 10/31 (32%) showed MYD88 mutations, which were not prognostically significant, and only three of them were L265P mutations. CARD11 mutations were found in 8/24 (33%) cases only. Immunophenotypically, the cases were predominantly GCB, in contrast to older adults (61%). In summary, we showed that molecular findings identified in the PCNSLs of the older patients were only sparingly present in pediatric and young adult patients.
Keyphrases
- middle aged
- young adults
- single cell
- genome wide
- physical activity
- copy number
- community dwelling
- end stage renal disease
- childhood cancer
- blood brain barrier
- ejection fraction
- magnetic resonance
- newly diagnosed
- genome wide identification
- chronic kidney disease
- dna methylation
- magnetic resonance imaging
- prognostic factors
- peritoneal dialysis
- healthcare
- african american
- inflammatory response
- patient reported outcomes
- immune response